1. Dong Y, Basmaci R, Titomanlio L, et al. (2020): Neonatal sepsis: within and beyond China. Chin Med J (Engl) 133: 2219-2228.
2.
Bethou A, Bhat BV (2022): Neonatal sepsis-newer insights. Indian J Pediatr 89: 267-273.
3.
Cantey JB, Lee JH (2021): Biomarkers for the diagnosis of neonatal sepsis. Clin Perinatol 48: 215-227.
4.
Zhang H, Liu J, Zhou Y, et al. (2022): Neutrophil extracellular traps mediate mA modification and regulates sepsis-associated acute lung injury by activating ferroptosis in alveolar epithelial cells. Int J Bio Sci 18: 3337-3357.
5.
Zhang J, Zheng Y, Wang Y, et al. (2022): YAP1 alleviates sepsis-induced acute lung injury inhibiting ferritinophagy- mediated ferroptosis. Front Immunol 13: 884362.
6.
Abu-Sultaneh S, Iyer N, Fernández A, et al. (2023): Executive summary: International clinical practice guidelines for pediatric ventilator liberation, a pediatric acute lung injury and sepsis investigators (PALISI) network document. Am J Respir Crit Care Med 207: 17-28.
7.
Wang X, Bai Y, Wang B (2024): Coactosin-like protein 1 (COTL1) could be an immunological and prognostic bio- marker: From pan-cancer analysis to low-grade glioma validation. J Inflamm Res 2024; 17: 1805-1820.
8.
Xia L, Xiao X, Liu W, et al. (2018): Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGFβ signaling. Oncogene 37: 323-331.
9.
Tan D, Chen XX, Bai T, et al. (2020): Sevoflurane up-regulates microRNA-204 to ameliorate myocardial ischemia/reperfusion injury in mice by suppressing Cotl1. Life Sci 259: 118162.
10.
Biwei M, Lirong Z, Qi W, et al. (2024): Diagnostic accuracy of pancreatic stone protein in patients with sepsis: a systematic review and meta-analysis. BMC Infect Dis 24: 472.
11.
Weihua S, Xiaoli L, Yongxing S, et al. (2023): PILRA is associated with immune cells infiltration in atrial fibrillation based on bioinformatics and experiment validation. Front Cardiovasc Med 10:1082015.
12.
Rashi S, Navkiran K, Rakhi M, et al. (2022): Plasma proteomic analysis identified proteins associated with faulty neutrophils functionality in decompensated cirrhosis patients with sepsis. Cells 11: 1745.
13.
Lan T, Chen B, Hu X, et al. (2024): Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK/NF-κB signaling pathway. J Ethnopharmacol 321: 117516.
14.
Wen J, Peng H, Wang D, et al. (2023): Lipopolysaccharides protect mesenchymal stem cell against cardiac ischemia-reperfusion injury by HMGB1/STAT3 signaling. J Geriatr Cardiol 20: 801-812.
15.
Guo Y, Zhang H, Lv Z, et al. (2023): Up-regulated CD38 by daphnetin alleviates lipopolysaccharide-induced lung injury via inhibiting MAPK/NF-κB/NLRP3 pathway. Cell Commun Signal 21: 66.
16.
Wang J, Xue X, Zhao X, et al. (2024): Forsythiaside A alleviates acute lung injury by inhibiting inflammation and epithelial barrier damages in lung and colon through PPAR-γ/RXR-α complex. J Adv Res 60: 183-200.
17.
Liu Z, Huang X, Guo H, et al. (2023): Design, synthesis fusidic acid derivatives alleviate acute lung injury via inhibiting MAPK/NF-κB/NLRP3 pathway. Eur J Med Chem 259: 115697.
18.
Popp A, Hettich J, Gebhardt JCM (2021): Altering transcription factor binding reveals comprehensive transcriptional kinetics of a basic gene. Nucleic Acids Res 49: 6249-6266.
19.
Miravet-Verde S, Lloréns-Rico V, Serrano L (2017): Alternative transcriptional regulation in genome-reduced bacteria. Curr Opin Microbiol 39: 89-95.
20.
Titcombe P, Silva Morales M, Zhang N, et al. (2023): BATF represses BIM to sustain tolerant T cells in the periphery. J Exp Med 220: e202320183.
21.
Zhang Z, Liao Q, Pan T, et al. (2023): BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism. Elife 12: RP88521.
22.
Guo H, Ni M, Xu J, et al. (2021): Transcriptional enhancement of GBP-5 by BATF aggravates sepsis-associated liver injury via NLRP3 inflammasome activation. FASEB J 35: e21672.
23.
Watanabe T, Lam C, Oliver J, et al. (2023): Donor Batf3 inhibits murine lung allograft rejection and airway fibrosis. Mucosal Immunol 16: 104-120.
24.
Bolognese A, Yang W, Hansen L, et al. (2018): Inhibition of necroptosis attenuates lung injury and improves survival in neonatal sepsis. Surgery 27: S0039-6060(18)30096-5.
25.
Zhang Y, Zhang J, Ren Y, et al. (2021): Luteolin suppresses sepsis-induced cold-inducible RNA-binding protein production and lung injury in neonatal mice. Shock 55: 268-273.
26.
Wong E, Nguyen N, Hellman J (2021): Isolation of primary mouse lung endothelial cells. J Vis Exp 177: 10.3791/63253.
27.
Mai J, He Q, Liu Y, et al. (2023): Hyperoside attenuates sepsis-induced acute lung injury (ALI) through autophagy regulation and inflammation suppression. Mediators Inflamm 2023: 1257615.
28.
Chen X, He H, Wei H, et al. (2023): Risk factors for death caused by early onset sepsis in neonates: a retrospective cohort study. BMC Infect Dis 23: 844.
29.
Mas-Celis F, Olea-López J, Parroquin-Maldonado JA (2021): Sepsis in trauma: A deadly complication. Arch Med Res 52: 808-816.
30.
Kwak M, Hwang C, Cha J, et al. (2023): Single-cell network-based drug repositioning for discovery of therapies against anti-tumour necrosis factor-resistant Crohn’s disease. Int J Mol Sci 24: 14099.
31.
Wang B, Zhao L, Chen D (2022): Coactosin-like protein in breast carcinoma: Friend or foe? J Inflamm Res 15: 4013-4025.
32.
Sehgal R, Kaur N, Maiwall R, et al. (2022): Plasma proteomic analysis identified proteins associated with faulty neutrophils functionality in decompensated cirrhosis patients with sepsis. Cells 11: 1745.
33.
Denorme F, Rustad J, Portier I, et al. (2023): Neutrophil extracellular trap inhibition improves survival in neonatal mouse infectious peritonitis. Pediatr Res 93: 862-869.
34.
Xu G, Chen H, Cong Z, et al. (2024): Promotion of transcription factor EB-dependent autophagic process by curcumin alleviates arsenic-caused lung oxidative stress and inflammation in mice. J Nutr Biochem 125: 109550.
35.
Jiang X, Zhu X, Liu Y, et al. (2023): Diallyl trisulfide and its active metabolite allyl methyl sulfone attenuate cisplatin-induced nephrotoxicity by inhibiting the ROS/MAPK/NF-κB pathway. Int Immunopharmacol 127: 111373.
36.
Wu X, Kasmani MY, Zheng S, et al. (2022): BATF promotes group 2 innate lymphoid cell-mediated lung tissue protection during acute respiratory virus infection. Sci Immunol 7: eabc9934.
37.
Pham D, Silberger D, Nguyen K, et al. (2023): Batf stabilizes Th17 cell development via impaired Stat5 recruitment of Ets1-Runx1 complexes. EMBO J 42: e109803.
